XML 53 R7.htm IDEA: XBRL DOCUMENT v3.25.4
Consolidated Statements of Stockholders' Equity (Deficiency) - USD ($)
$ in Thousands
Total
Ordinary shares
Additional Paid-in Capital [Member]
Treasury Stock, Common [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Price Adjustment Shares [Member]
Public and Private Warrant
Beginning balance (in shares) at Dec. 31, 2022   193,014,155            
Beginning balance at Dec. 31, 2022 $ 73,865 $ 0 $ (125,624) $ (85) $ 331 $ 199,243    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net Income (Loss) (81,100)         (81,100)    
Other comprehensive income (loss) 719       719      
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition 18,998   18,998          
Exercise of share option, vested RSUs and ESPP (in shares)   10,216,773            
Stock Issued During Period, Value, Stock Options Exercised     21,730          
Stock Issued During Period, Value, Employee Stock Purchase Plan   $ 0            
Reclassification and release of Restricted Sponsor Shares 0              
Ending balance (in shares) at Dec. 31, 2023   203,230,928            
Ending balance at Dec. 31, 2023 34,212 $ 0 (84,896) (85) 1,050 118,143    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net Income (Loss) (283,007)         (283,007)    
Other comprehensive income (loss) 1,036       1,036      
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition 30,575   30,575          
Exercise of share option, vested RSUs and ESPP (in shares)   9,688,962            
Stock Issued During Period, Value, Stock Options Exercised 20,479   20,479          
Reclassification and release of Restricted Sponsor Shares 113,136   113,136          
Price Adjustment Shares [Member] 254,766   254,766          
Publicand PrivateWarrants $ 164,823   164,823          
Conversion of preferred shares (in shares)             11,495,722 10,109,085
Ending balance (in shares) at Dec. 31, 2024 234,524,697              
Ending balance at Dec. 31, 2024 $ 336,020 $ 0 498,883 (85) 2,086 (164,864)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net Income (Loss) 78,326         78,326    
Other comprehensive income (loss) 134       134      
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition $ 44,892   44,892          
Exercise of share option, vested RSUs and ESPP (in shares) 5,559,075 10,552,067            
Common Stock, Capital Shares Reserved for Future Issuance   3,504,278            
Stock Issued During Period, Value, Stock Options Exercised $ 24,946   24,946          
Stock Issued During Period, Value, Employee Stock Purchase Plan   $ 0            
Issuance of Price Adjustments Value   0            
Reclassification and release of Restricted Sponsor Shares $ 0              
Conversion of preferred shares (in shares)             15,000,000  
Ending balance (in shares) at Dec. 31, 2025 248,581,042              
Ending balance at Dec. 31, 2025 $ 484,318 $ 0 $ 568,721 $ (85) $ 2,220 $ (86,538)